Prescription of aspirin for adults with diabetes

P. Sabitha, Asha Kamath, Prabha M. Adhikari

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: To evaluate the prescription of aspirin for primary and secondary prevention of cardiovascular disorders in diabetic patients, in the light of American Diabetes Association recommendations. Materials and Methods: In this retrospective analysis, presence of any cardiovascular disease or cardiovascular disease risk factor as defined in American Diabetes Association guidelines and the use of aspirin and other medication data were extracted from the case files of 100 patients with type 2 diabetes mellitus visiting two teaching hospitals. Results: Of 100 patients studied, 58% were men and 42% women, and all were ≥ 40 years of age. 45% had at least one cardiovascular disease and all (100%) were on aspirin for secondary prevention; 45% had one or more risk factors alone, of which 11% (05/45) had aspirin prescribed for primary prevention; remaining 10% had neither risk factors nor cardiovascular disease (but age ≥ 40 years) and no aspirin documentation. Reasons for not using aspirin/antiplatelet drug were not recorded. Conclusions: American Diabetes Association recommendations for aspirin use for secondary prevention of cardiovascular diseases were strictly adhered to, in contrast to that for primary prevention. Under-prescription of aspirin could be attributed to the physicians′ concern about the burden of poly-pharmacy and toxic effects of aspirin on long-term use. Extensive efforts are necessary to enhance aspirin use in this regard.

Original languageEnglish
Pages (from-to)51-53
Number of pages3
JournalInternational Journal of Diabetes in Developing Countries
Volume28
Issue number2
DOIs
Publication statusPublished - 01-04-2008

Fingerprint

Aspirin
Prescriptions
Cardiovascular Diseases
Primary Prevention
Secondary Prevention
Poisons
Platelet Aggregation Inhibitors
Teaching Hospitals
Documentation
Type 2 Diabetes Mellitus
Guidelines
Physicians

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

@article{5118982b02b945a6b4529af27eca3c8d,
title = "Prescription of aspirin for adults with diabetes",
abstract = "Background: To evaluate the prescription of aspirin for primary and secondary prevention of cardiovascular disorders in diabetic patients, in the light of American Diabetes Association recommendations. Materials and Methods: In this retrospective analysis, presence of any cardiovascular disease or cardiovascular disease risk factor as defined in American Diabetes Association guidelines and the use of aspirin and other medication data were extracted from the case files of 100 patients with type 2 diabetes mellitus visiting two teaching hospitals. Results: Of 100 patients studied, 58{\%} were men and 42{\%} women, and all were ≥ 40 years of age. 45{\%} had at least one cardiovascular disease and all (100{\%}) were on aspirin for secondary prevention; 45{\%} had one or more risk factors alone, of which 11{\%} (05/45) had aspirin prescribed for primary prevention; remaining 10{\%} had neither risk factors nor cardiovascular disease (but age ≥ 40 years) and no aspirin documentation. Reasons for not using aspirin/antiplatelet drug were not recorded. Conclusions: American Diabetes Association recommendations for aspirin use for secondary prevention of cardiovascular diseases were strictly adhered to, in contrast to that for primary prevention. Under-prescription of aspirin could be attributed to the physicians′ concern about the burden of poly-pharmacy and toxic effects of aspirin on long-term use. Extensive efforts are necessary to enhance aspirin use in this regard.",
author = "P. Sabitha and Asha Kamath and Adhikari, {Prabha M.}",
year = "2008",
month = "4",
day = "1",
doi = "10.4103/0973-3930.43099",
language = "English",
volume = "28",
pages = "51--53",
journal = "International Journal of Diabetes in Developing Countries",
issn = "0973-3930",
publisher = "Springer India",
number = "2",

}

Prescription of aspirin for adults with diabetes. / Sabitha, P.; Kamath, Asha; Adhikari, Prabha M.

In: International Journal of Diabetes in Developing Countries, Vol. 28, No. 2, 01.04.2008, p. 51-53.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prescription of aspirin for adults with diabetes

AU - Sabitha, P.

AU - Kamath, Asha

AU - Adhikari, Prabha M.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Background: To evaluate the prescription of aspirin for primary and secondary prevention of cardiovascular disorders in diabetic patients, in the light of American Diabetes Association recommendations. Materials and Methods: In this retrospective analysis, presence of any cardiovascular disease or cardiovascular disease risk factor as defined in American Diabetes Association guidelines and the use of aspirin and other medication data were extracted from the case files of 100 patients with type 2 diabetes mellitus visiting two teaching hospitals. Results: Of 100 patients studied, 58% were men and 42% women, and all were ≥ 40 years of age. 45% had at least one cardiovascular disease and all (100%) were on aspirin for secondary prevention; 45% had one or more risk factors alone, of which 11% (05/45) had aspirin prescribed for primary prevention; remaining 10% had neither risk factors nor cardiovascular disease (but age ≥ 40 years) and no aspirin documentation. Reasons for not using aspirin/antiplatelet drug were not recorded. Conclusions: American Diabetes Association recommendations for aspirin use for secondary prevention of cardiovascular diseases were strictly adhered to, in contrast to that for primary prevention. Under-prescription of aspirin could be attributed to the physicians′ concern about the burden of poly-pharmacy and toxic effects of aspirin on long-term use. Extensive efforts are necessary to enhance aspirin use in this regard.

AB - Background: To evaluate the prescription of aspirin for primary and secondary prevention of cardiovascular disorders in diabetic patients, in the light of American Diabetes Association recommendations. Materials and Methods: In this retrospective analysis, presence of any cardiovascular disease or cardiovascular disease risk factor as defined in American Diabetes Association guidelines and the use of aspirin and other medication data were extracted from the case files of 100 patients with type 2 diabetes mellitus visiting two teaching hospitals. Results: Of 100 patients studied, 58% were men and 42% women, and all were ≥ 40 years of age. 45% had at least one cardiovascular disease and all (100%) were on aspirin for secondary prevention; 45% had one or more risk factors alone, of which 11% (05/45) had aspirin prescribed for primary prevention; remaining 10% had neither risk factors nor cardiovascular disease (but age ≥ 40 years) and no aspirin documentation. Reasons for not using aspirin/antiplatelet drug were not recorded. Conclusions: American Diabetes Association recommendations for aspirin use for secondary prevention of cardiovascular diseases were strictly adhered to, in contrast to that for primary prevention. Under-prescription of aspirin could be attributed to the physicians′ concern about the burden of poly-pharmacy and toxic effects of aspirin on long-term use. Extensive efforts are necessary to enhance aspirin use in this regard.

UR - http://www.scopus.com/inward/record.url?scp=53849128913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849128913&partnerID=8YFLogxK

U2 - 10.4103/0973-3930.43099

DO - 10.4103/0973-3930.43099

M3 - Article

AN - SCOPUS:53849128913

VL - 28

SP - 51

EP - 53

JO - International Journal of Diabetes in Developing Countries

JF - International Journal of Diabetes in Developing Countries

SN - 0973-3930

IS - 2

ER -